Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 2.800
+0.150 (5.66%)
Jul 28, 2026, 8:18 AM GMT
Renalytix Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 6.1 | 3.6 | 4.7 | 24.68 | 41.33 | 65.16 |
Short-Term Investments | 0.1 | 0.1 | 0.7 | 1.46 | 2.74 | 9.3 |
Cash & Short-Term Investments | 6.2 | 3.7 | 5.4 | 26.14 | 44.08 | 74.45 |
Cash Growth | -35.42% | -31.48% | -79.34% | -40.69% | -40.80% | 421.57% |
Accounts Receivable | 1.3 | 0.6 | 0.7 | 0.78 | 0.9 | 0.59 |
Inventory | 0.3 | 0.2 | 0.3 | 0.72 | 1.16 | 0.35 |
Other Current Assets | 0.7 | 1.3 | 0.4 | 0.7 | 1.29 | 0.61 |
Total Current Assets | 8.5 | 5.8 | 6.8 | 28.33 | 47.43 | 76.01 |
Net Property, Plant & Equipment | 1.3 | 0.2 | 0.2 | 1.22 | 1.72 | 1.38 |
Other Intangible Assets | - | - | - | 12.51 | 14.02 | 18.02 |
Long-Term Investments | - | - | - | - | 0.01 | - |
Other Long-Term Assets | 0.1 | 0.1 | 0.1 | 0.05 | 0.08 | 7.17 |
Total Assets | 9.9 | 6.1 | 7.1 | 42.12 | 63.26 | 102.58 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 5.3 | 4.8 | 7.6 | 11.51 | 7.28 | 6.65 |
Short-Term Debt | - | - | - | - | - | 0.05 |
Current Portion of Long-Term Debt | - | - | 4.2 | 4.46 | 4.66 | - |
Current Portion of Leases | 0.2 | - | 0 | 0.16 | 0.16 | 0.09 |
Unearned Revenue | - | - | - | - | 0.05 | 0.12 |
Other Current Liabilities | - | - | - | - | 0.06 | 0.35 |
Total Current Liabilities | 5.4 | 4.8 | 11.8 | 16.13 | 12.21 | 7.26 |
Long-Term Debt | 4.7 | 8.3 | 4.3 | 7.49 | 7.68 | - |
Long-Term Leases | 0.9 | - | - | 0.05 | 0.2 | 0.21 |
Total Long-Term Liabilities | 5.6 | 8.3 | 4.3 | 7.53 | 7.88 | 0.21 |
Total Liabilities | 11 | 13.1 | 16.1 | 23.66 | 20.09 | 7.48 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 1.4 | 1.1 | 0.5 | 0.3 | 0.24 | 0.23 |
Additional Paid-in Capital | 172.5 | 159 | 136.3 | 118.47 | 97.4 | 81.4 |
Accumulated Other Comprehensive Income | -1.7 | -2 | -1.1 | -1.13 | -1.51 | 9.7 |
Retained Earnings | -173.4 | -165.1 | -144.7 | -99.18 | -52.96 | 3.77 |
Shareholders' Equity | -1.2 | -7 | -9 | 18.45 | 43.17 | 95.1 |
Total Liabilities & Equity | 9.9 | 6.1 | 7.1 | 42.12 | 63.26 | 102.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 5.8 | 8.3 | 8.5 | 12.15 | 12.71 | 0.35 |
Net Cash (Debt) | 0.4 | -4.6 | -3.1 | 13.99 | 31.37 | 74.1 |
Net Cash Growth | -71.43% | - | - | -55.40% | -57.67% | 442.75% |
Net Cash Per Share | 0.00 | -0.02 | -0.03 | 0.17 | 0.42 | 1.04 |
Book Value | -1.2 | -7 | -9 | 18.45 | 43.17 | 95.1 |
Book Value Per Share | -0.00 | -0.03 | -0.08 | 0.22 | 0.58 | 1.33 |
Tangible Book Value | -1.2 | -7 | -9 | 5.94 | 29.15 | 77.08 |
Tangible Book Value Per Share | -0.00 | -0.03 | -0.08 | 0.07 | 0.39 | 1.08 |